|
|
| | beta-Mercapto-beta,beta-cyclopentamethylene-propionyl-Tyr(Et)-Phe-Val-Asn-Cys-Pro-Arg-Gly-NH2 Basic information |
| Product Name: | beta-Mercapto-beta,beta-cyclopentamethylene-propionyl-Tyr(Et)-Phe-Val-Asn-Cys-Pro-Arg-Gly-NH2 | | Synonyms: | (B-MERCAPTO-B,B-CYCLOPENTAMETHYLENE-*PRO PIONYL1,O-E;[β-mercapto-β,β-cyclopentamethylenepropionyl1, o-et-tyr2, val4, arg8]-vasopressin;1-(1-MERCAPTOCYCLOHEXANEACETIC ACID)-2-(O-ETHYL-L-TYROSINE)-4-L- VALINE-8-L-ARGININEVASOPRESSIN;vasopressin 1-(1-MCHA)-2-(O-ethyl-L-tyrosine)-4-L-valine;[BETA-MERCAPTO-BETA,BETA-CYCLOPENTAMETHYLENEPROPIONYL1,O-ET-TYR2,VAL4,ARG8]-VASOPRESSIN;(D(CH2)(5/1),TYR(ET)2,VAL4,ARG8)-VASOPRESSIN;[1-MERCAPTOCYCLOHEXYL]ACETYL-TYR[O-ETHYL]-PHE-VAL-ASN-CYS-PRO-ARG-GLY-NH2;M.W. 1136.41 C53H77N13O11S2 | | CAS: | 77453-01-1 | | MF: | C53H77N13O11S2 | | MW: | 1136.39 | | EINECS: | | | Product Categories: | Vasopressin and Oxytocin receptor;Hormones;Oxytocin&Vasopressin;Pituitary Hormones;VasopressinPeptides for Cell Biology;Vasopressins | | Mol File: | 77453-01-1.mol |  |
| | beta-Mercapto-beta,beta-cyclopentamethylene-propionyl-Tyr(Et)-Phe-Val-Asn-Cys-Pro-Arg-Gly-NH2 Chemical Properties |
| storage temp. | −20°C | | form | Solid | | color | White to off-white | | Sequence | {(1-Mercaptocyclohexyl)acetyl}-{Tyr(O-Ethyl)}-Phe-Val-Asn-Cys-Pro-Arg-Gly-NH2 (Disulfide bridge: 1-Cys6) |
| Hazard Codes | Xn | | Risk Statements | 20 | | Safety Statements | 36 | | WGK Germany | 3 |
| | beta-Mercapto-beta,beta-cyclopentamethylene-propionyl-Tyr(Et)-Phe-Val-Asn-Cys-Pro-Arg-Gly-NH2 Usage And Synthesis |
| Uses | SKF 100398 (d(CH2)5Tyr(Et)VAVP), an arginine vasopressin (AVP) analogue, is a specific antagonist of the antidiuretic effect of exogenous and endogenous AVP[1]. | | in vivo | SKF 100398 is a specific antagonist of the hydrosmotic effect of exogenous and endogenous AVP[1]. SKF 100398 (8 μg/kg; i.v.) abolishes the antidiuretic effect of AVP[1].
| Animal Model: | Male Sprague-Dawley rats (250-300 g)[1] | | Dosage: | 8 μg/kg | | Administration: | Intravenous injection | | Result: | Completely blocked the antidiuretic effect of exogenous AVP (4 ng/kg body wt i.v.). |
| | References | [1] S Ishikawa, et al. Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin. Am J Physiol. 1983 Nov;245(5 Pt 1):R713-9. DOI:10.1152/ajpregu.1983.245.5.R713 |
| | beta-Mercapto-beta,beta-cyclopentamethylene-propionyl-Tyr(Et)-Phe-Val-Asn-Cys-Pro-Arg-Gly-NH2 Preparation Products And Raw materials |
|